Future Proofing Against Forever Chemicals: Navigating the Impact of a PFAS Ban on Parenteral Packaging

PFAS are a large category of synthetic substances known for their strong fluorine-carbon bonds – a significant advantage in many pharmaceutical applications but a major concern when it comes to their environmental impact. With a potential EU-wide ban on the horizon, this whitepaper considers the potential impact on pharmaceutical supply chains, including information on how Datwyler is navigating the situation.